A research team led by Children’s National Health System uses a preclinical model to demonstrate that SVZ NSPCs contribute to perinatal corticogenesis and to suggest that restoration of SVZ NSPCs’ neurogenic potential is a candidate therapeutic target for improving cortical growth in CHD.
25 янв 2017
